Update on InnomarClinics
InnomarClinics remain open to our patients amidst coronavirus (COVID-19) concerns.
Learn more.

Explore by topic

All Topics

Market Access

10 Results

Innomar Strategies

Webinar: 2020 pan-Canadian Oncology Drug Review (pCODR) Updates

Inverted color AmerisourceBergen icon
Innomar Strategies
September 2020

Manufacturers

Webinar: Utilizing Real World Evidence Across the Product Life Cycle

Inverted color AmerisourceBergen icon
Innomar Strategies
June 2020

Manufacturers

Why Canada: Leveraging our partnerships and relationships to assist in your launch strategy.

Sandra Anderson
Sandra Anderson
Commercialization and Strategy
March 2020

Manufacturers

Why Canada: How we help Pharmaceutical Manufacturers commercialize their products in Canada.

Sandra Anderson
Sandra Anderson
Commercialization and Strategy
February 2020

Manufacturers

Why Canada: Is Canada an attractive market for global pharmaceutical manufacturers?

Sandra Anderson
Sandra Anderson
Commercialization and Strategy
January 2020

Manufacturers

InnomarLive 2019: Commercializing in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
December 2019

Infographic: The Route to Market Access in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
May 2018

Infographic: The Road to Commercialization in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
May 2018

Insight Series: Biosimilars in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
January 2018

Future of Patient Support Programs in Canada

Sandra Anderson
Sandra Anderson
Commercialization and Strategy
June 2016